Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Original Article

α-Lipoic Acid Prevents the Induction of iNOS Gene Expression Through Destabilization of Its mRNA in Proinflammatory Cytokine-Stimulated Hepatocytes

Authors: Masanori Yamada, Masaki Kaibori, Hironori Tanaka, Kozo Habara, Takeshi Hijikawa, Yoshito Tanaka, Masaharu Oishi, Tadayoshi Okumura, Mikio Nishizawa, A-Hon Kwon

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Abstract

Background/Aims

α-Lipoic acid (α-LA) has been reported to reduce ischemia–reperfusion injury (IRI). Proinflammatory cytokines stimulate the induction of inducible nitric oxide synthase (iNOS) gene expression, leading to excess production of NO and resulting in liver injury including IRI. We hypothesized that inhibition of iNOS induction underlies the protective effects of α-LA on the liver. The objective was to investigate whether α-LA directly influences iNOS induction in cultured hepatocytes, which is used as a simple in vitro injury model, and the mechanism involved.

Methods

Primary cultured rat hepatocytes were treated with interleukin (IL)-1β in the presence or absence of α-LA. The induction of iNOS and NO production and its signal were analyzed.

Results

α-LA inhibited the expression of iNOS mRNA and protein dose- and time-dependently, resulting in decreases in NO production. α-LA had no effects on the degradation of IκB proteins and activation of NF-κB. In contrast, α-LA inhibited the upregulation of type I IL-1 receptor stimulated by IL-1β, although α-LA had no effect on Akt activation. Transfection experiments with iNOS promoter-luciferase constructs revealed that α-LA had no effect on the transactivation of the iNOS promoter, but decreased the stabilization of iNOS mRNA. Further, α-LA inhibited the expression of an iNOS gene antisense-transcript, which is involved in iNOS mRNA stability.

Conclusions

Results indicate that α-LA inhibits the induction of iNOS gene expression at a posttranscriptional step via iNOS mRNA stabilization, rather than promoter activation. It may provide useful therapeutic effects through the suppression of iNOS induction involved in liver injury.
Literature
1.
go back to reference Moini H, Packer L, Saris NE. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol. 2002;182:84–90.PubMedCrossRef Moini H, Packer L, Saris NE. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol. 2002;182:84–90.PubMedCrossRef
2.
go back to reference Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition. 2001;17:888–895.PubMedCrossRef Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition. 2001;17:888–895.PubMedCrossRef
3.
go back to reference Saliou C, Kitazawa M, McLaughlin L, et al. Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line. Free Radic Biol Med. 1999;26:174–183.PubMedCrossRef Saliou C, Kitazawa M, McLaughlin L, et al. Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line. Free Radic Biol Med. 1999;26:174–183.PubMedCrossRef
4.
go back to reference Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3–L1 adipocytes. Diabetologia. 2000;43:294–303.PubMedCrossRef Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3–L1 adipocytes. Diabetologia. 2000;43:294–303.PubMedCrossRef
5.
go back to reference Konrad D, Somwar R, Sweeney G, et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes. 2001;50:1464–1471.PubMedCrossRef Konrad D, Somwar R, Sweeney G, et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes. 2001;50:1464–1471.PubMedCrossRef
6.
go back to reference Kiemer AK, Müller C, Vollmar AM. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol Cell Biol. 2002;80:550–557.PubMedCrossRef Kiemer AK, Müller C, Vollmar AM. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol Cell Biol. 2002;80:550–557.PubMedCrossRef
7.
go back to reference Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917–936.PubMedCrossRef Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917–936.PubMedCrossRef
8.
go back to reference Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol. 2003;285:G769–G778.PubMed Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol. 2003;285:G769–G778.PubMed
9.
go back to reference Dünschede F, Erbes K, Kircher A, et al. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by alpha-lipoic acid in humans. World J Gastroenterol. 2006;12:6812–6817.PubMed Dünschede F, Erbes K, Kircher A, et al. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by alpha-lipoic acid in humans. World J Gastroenterol. 2006;12:6812–6817.PubMed
10.
go back to reference Tsuchiya H, Kaibori M, Yanagida H, et al. Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol. 2004;40:94–101.PubMedCrossRef Tsuchiya H, Kaibori M, Yanagida H, et al. Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol. 2004;40:94–101.PubMedCrossRef
11.
go back to reference Tsuji K, Kwon A-H, Yoshida H, et al. Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol. 2005;42:94–101.PubMedCrossRef Tsuji K, Kwon A-H, Yoshida H, et al. Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol. 2005;42:94–101.PubMedCrossRef
12.
go back to reference Tanaka H, Uchida Y, Kaibori M, et al. Okumura T: Na+/H+ exchanger inhibitor, FR183998, has protective effect in lethal acute liver failure and prevents iNOS induction in rats. J Hepatol. 2008;48:289–299.PubMedCrossRef Tanaka H, Uchida Y, Kaibori M, et al. Okumura T: Na+/H+ exchanger inhibitor, FR183998, has protective effect in lethal acute liver failure and prevents iNOS induction in rats. J Hepatol. 2008;48:289–299.PubMedCrossRef
13.
go back to reference Hijikawa T, Kaibori M, Uchida Y, et al. Insulin-like growth factor-I prevents liver injury through the inhibition of TNF-α and iNOS induction in D-galactosamine and lipopolysaccharide-treated rats. Shock. 2008;29:740–747.PubMed Hijikawa T, Kaibori M, Uchida Y, et al. Insulin-like growth factor-I prevents liver injury through the inhibition of TNF-α and iNOS induction in D-galactosamine and lipopolysaccharide-treated rats. Shock. 2008;29:740–747.PubMed
14.
go back to reference Ishizaki M, Kaibori M, Uchida Y, et al. Protective effect of FR183998, a Na+/H+ exchanger inhibitor, and its inhibition of iNOS induction in hepatic ischemia-reperfusion injury in rats. Shock. 2008;30:311–317.PubMedCrossRef Ishizaki M, Kaibori M, Uchida Y, et al. Protective effect of FR183998, a Na+/H+ exchanger inhibitor, and its inhibition of iNOS induction in hepatic ischemia-reperfusion injury in rats. Shock. 2008;30:311–317.PubMedCrossRef
15.
go back to reference Nakanishi H, Kaibori M, Teshima S, et al. Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1β at a step of NF-kB DNA binding in hepatocytes. J Hepatol. 2004;41:730–736.PubMedCrossRef Nakanishi H, Kaibori M, Teshima S, et al. Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1β at a step of NF-kB DNA binding in hepatocytes. J Hepatol. 2004;41:730–736.PubMedCrossRef
16.
go back to reference Yoshida H, Kwon A-H, Kaibori M, et al. Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. Nitric Oxide Biol Chem. 2008;18:105–112.CrossRef Yoshida H, Kwon A-H, Kaibori M, et al. Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. Nitric Oxide Biol Chem. 2008;18:105–112.CrossRef
17.
go back to reference Kanemaki T, Kitade H, Hiramatsu Y, Kamiyama Y, Okumura T. Stimulation of glycogen degradation by prostaglandin E2 in primary cultured rat hepatocytes. Prostaglandins. 1993;45:459–474.PubMedCrossRef Kanemaki T, Kitade H, Hiramatsu Y, Kamiyama Y, Okumura T. Stimulation of glycogen degradation by prostaglandin E2 in primary cultured rat hepatocytes. Prostaglandins. 1993;45:459–474.PubMedCrossRef
18.
go back to reference Selgen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29–83.CrossRef Selgen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29–83.CrossRef
19.
go back to reference Horiuti Y, Ogishima M, Yano K, Shibuya Y. Quantification of cell nuclei isolated from hepatocytes by cell lysis with nonionic detergent in citric acid. Cell Struct Funct. 1991;16:203–207.PubMedCrossRef Horiuti Y, Ogishima M, Yano K, Shibuya Y. Quantification of cell nuclei isolated from hepatocytes by cell lysis with nonionic detergent in citric acid. Cell Struct Funct. 1991;16:203–207.PubMedCrossRef
20.
go back to reference Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131–138.PubMedCrossRef Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131–138.PubMedCrossRef
21.
go back to reference Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159.PubMedCrossRef Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159.PubMedCrossRef
22.
go back to reference Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89–94.PubMedCrossRef Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89–94.PubMedCrossRef
23.
go back to reference Hart RP, Liu C, Shadiack AM, McCormack RJ, Jonakait GM. An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia. J Neuroimmunol. 1993;44:49–56.PubMedCrossRef Hart RP, Liu C, Shadiack AM, McCormack RJ, Jonakait GM. An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia. J Neuroimmunol. 1993;44:49–56.PubMedCrossRef
24.
go back to reference Sabath DE, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 1990;91:185–191.PubMedCrossRef Sabath DE, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 1990;91:185–191.PubMedCrossRef
25.
go back to reference Nishizawa M, Nakajima T, Yasuda K, et al. Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes. Genes Cells. 2000;5:111–125.PubMedCrossRef Nishizawa M, Nakajima T, Yasuda K, et al. Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes. Genes Cells. 2000;5:111–125.PubMedCrossRef
26.
go back to reference Unezaki S, Nishizawa M, Okuda-Ashitaka E, et al. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors. Gene. 2004;336:47–58.PubMedCrossRef Unezaki S, Nishizawa M, Okuda-Ashitaka E, et al. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors. Gene. 2004;336:47–58.PubMedCrossRef
27.
go back to reference Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.PubMedCrossRef Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.PubMedCrossRef
28.
go back to reference Oda M, Sakitani K, Kaibori M, Inoue T, Kamiyama Y, Okumura T. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits iNOS gene expression at a step of NF-κB DNA binding in hepatocytes. J Biol Chem. 2000;275:4369–4373.PubMedCrossRef Oda M, Sakitani K, Kaibori M, Inoue T, Kamiyama Y, Okumura T. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits iNOS gene expression at a step of NF-κB DNA binding in hepatocytes. J Biol Chem. 2000;275:4369–4373.PubMedCrossRef
29.
go back to reference Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.PubMedCrossRef Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.PubMedCrossRef
30.
go back to reference Inoue T, Kwon A-H, Oda M, et al. Hypoxia and heat inhibit inducible nitric oxide synthase gene expression by different mechanisms in rat hepatocytes. Hepatology. 2000;32:1037–1044.PubMedCrossRef Inoue T, Kwon A-H, Oda M, et al. Hypoxia and heat inhibit inducible nitric oxide synthase gene expression by different mechanisms in rat hepatocytes. Hepatology. 2000;32:1037–1044.PubMedCrossRef
31.
go back to reference Yamada M, Nishizawa M, Nakatake R, et al. Characterization of alternatively spliced isoforms of the type I interleukin-1 receptor on iNOS induction in rat hepatocytes. Nitric Oxide Biol Chem. 2007;17:98–105.CrossRef Yamada M, Nishizawa M, Nakatake R, et al. Characterization of alternatively spliced isoforms of the type I interleukin-1 receptor on iNOS induction in rat hepatocytes. Nitric Oxide Biol Chem. 2007;17:98–105.CrossRef
32.
go back to reference Sakitani K, Kitade H, Inoue K, et al. Anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not a transcriptional step, in hepatocytes. Hepatology. 1997;25:416–420.PubMedCrossRef Sakitani K, Kitade H, Inoue K, et al. Anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not a transcriptional step, in hepatocytes. Hepatology. 1997;25:416–420.PubMedCrossRef
33.
go back to reference Kitade H, Sakitani K, Inoue K, et al. Interleukin-1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes, but not in Kupffer cells. Hepatology. 1996;23:797–802.PubMed Kitade H, Sakitani K, Inoue K, et al. Interleukin-1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes, but not in Kupffer cells. Hepatology. 1996;23:797–802.PubMed
34.
go back to reference Teshima S, Nakanishi H, Nishizawa M, et al. Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J Hepatol. 2004;40:616–623.PubMedCrossRef Teshima S, Nakanishi H, Nishizawa M, et al. Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J Hepatol. 2004;40:616–623.PubMedCrossRef
35.
go back to reference Matsui K, Nishizawa M, Ozaki T, et al. Natural antisense transcript stabilizes inducible nitric oxide synthase mRNA in rat hepatocytes. Hepatology. 2008;47:686–697.PubMedCrossRef Matsui K, Nishizawa M, Ozaki T, et al. Natural antisense transcript stabilizes inducible nitric oxide synthase mRNA in rat hepatocytes. Hepatology. 2008;47:686–697.PubMedCrossRef
36.
go back to reference Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol. 2004;500:255–266.PubMedCrossRef Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol. 2004;500:255–266.PubMedCrossRef
37.
go back to reference Pautz A, Linker K, Hubrich R, Korhonen R, Altenhofer S, Kleivert H. The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J Biol Chem. 2006;281:32294–32302.PubMedCrossRef Pautz A, Linker K, Hubrich R, Korhonen R, Altenhofer S, Kleivert H. The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J Biol Chem. 2006;281:32294–32302.PubMedCrossRef
38.
go back to reference Hines IN, Kawachi S, Harada H, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem. 2002;234–235:229–237.PubMedCrossRef Hines IN, Kawachi S, Harada H, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem. 2002;234–235:229–237.PubMedCrossRef
Metadata
Title
α-Lipoic Acid Prevents the Induction of iNOS Gene Expression Through Destabilization of Its mRNA in Proinflammatory Cytokine-Stimulated Hepatocytes
Authors
Masanori Yamada
Masaki Kaibori
Hironori Tanaka
Kozo Habara
Takeshi Hijikawa
Yoshito Tanaka
Masaharu Oishi
Tadayoshi Okumura
Mikio Nishizawa
A-Hon Kwon
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-2012-4

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.